Hospitalisation costs for community-acquired pneumonia (CAP) in France (F), Germany (D), Japan (J) and USA Source: Eur Respir J 2004; 24: Suppl. 48, 8s Year: 2004
Asthma treatment: influence of psychology rehabilitation (PR) on the course of disease (CD), psychological status (PS) and the smoking cessation rate (SCR) Source: Eur Respir J 2005; 26: Suppl. 49, 487s Year: 2005
Bio-Chip (BCh) technology for diagnostics of multidrug resistance (DR) of mycobacterium tuberculosis (MBT) from patients with disseminated tuberculosis (DT) Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Are we missing asthma COPD overlap (ACO) diagnosis among patient with COPD?Alameeri Amel(1), Dudina Alexandra(1) , Stephen Lane(1), Kennedy Merian(2) Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019
The impact of antimicrobial resistance on the cost-effectiveness of empirical treatment of community-acquired pneumonia (CAP) in France (FR), Belgium (BE) and Germany (DE) Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Drug sensitivity pattern (first line ATT) in DOTS failure & relapse cases (Cat I & Cat II) rntcp, India Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Asthma control (AC) 1 year after pulmonary rehabilitation (PR) Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Doctors (drs) knowledge of diagnosing, investigating & managing pulmonary embolus (PE) in pregnancy? Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012
The use of phon resonant therapy (PRT) in treatment of patients with pulmonary tuberculosis, combined with infections, caused by chlamydia (C) and mycoplasma (M) Source: Eur Respir J 2004; 24: Suppl. 48, 52s Year: 2004
Primary resistance (PR) of mycobacterium tuberculosis (MBT) to antimicrobial drugs (AMBD) in patients (P) with destructive pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004
The opinions of people living with chronic respiratory disease (CRD) and healthcare professionals (HCPs) about Pulmonary Rehabilitation (PR) in Kyrgyzstan. Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe Year: 2020
Acceptance, and compliance to treatment for latent tuberculous infection (LTBI) in Geneva (1993-2002) Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005
Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015
Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014
Determination of community acquired pneumonia (CAP) severity in pregnant (pr.) Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021
Gender and other risk factors for multidrug-resistant (MDR) tuberculosis (TB) among migrants to Milan, Italy Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Diagnostic aspects of chronic berylliosis (CB) and sarcoidosis (S) Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006
Bone and joint tuberculosis in Bradford: a 6 year review (1999-2004) Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005
Illness perception in tuberculosis (TB) patients by implementation of the brief illness perception questionnaire (BIPQ) – a multi-centre study Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009